In conclusion, investigating aetiological and prognostic heterogeneity among IHC defined subtypes of breast cancer requires the incorporation of measures of Ki67 and other IHC markers in large‐scale collaborative molecular epidemiological studies. The gene discussed is MKI67; the disease is breast carcinoma.